PubMed Health⌕ Search

Biomedical subjects

G R Passi

Publications and source records attributed to G R Passi.

14 recordsLinked to original sources

Biotinidase deficiency--a treatable entity.

Biotinidase deficiency is a well recognised treatable cause of a wide spectrum of progressive neurological symptoms. Recent reports have stressed the need to screen children with early onset of seizures, encephalopathy, neurodevelopmental delay, skin rash and alopecia. Enzyme estimation remains the conclusive test. We present a patient with biotinidase deficiency suspected on the above clinical grounds and diagnosed on the basis of metabolic acidosis, raised blood lactate, ketonuria and positive dinitrophenylhydrazine (DNPH) test and confirmed on urinary organic acid profile. Supplementation with biotin resulted in marked clinical improvement and normalisation of metabolic parameters. Thus the clinician should be alert to simple clinical pointers which aid in early diagnosis of these disorders.

Amidohydrolases↗

Analysis of childhood epileptic encephalopathies with regard to etiological and prognostic factors.

To analyse the clinical characteristics of patients with childhood epileptic encephalopathies, a retrospective study was carried out on paediatric neurology clinic records of a tertiary hospital. Forty-five children with childhood epileptic encephalopathies were identified. Patients were classified according to the international classification of epilepsies and epileptic syndromes, data were collected regarding age at onset, perinatal problems, presence of psychomotor retardation, radiological findings, etiology and response to therapy. Characteristics of responders versus non-responders were compared. The majority had West syndrome (29/45 or 64.4%). Of the total, 37/45 or 82.2% were symptomatic. The etiologic factors identified included perinatal problems in 24/45 or 53.3%, one patient with tuberous sclerosis and one with Aicardi's syndrome. Psychomotor retardation was seen in 95.5%. Cranial CT scan was normal in 11/26 or 42.3%. Abnormalities included infarcts (4/26), generalised atrophy and hydrocephalus (3/26), porencephalic cysts (2/26) and agenesis of corpus callosum, tuberous sclerosis, gliosis and subdural effusion (one each). Mean follow-up was 18 months and 71.4% responded to ACTH. There was no significant difference between responders and non-responders.

Adrenocorticotropic Hormone↗

Technology.

Explore the source record for details and available documents.

Animals↗

Clinico-hematological spectrum of auto-immune hemolytic anemia: an Indian experience.

Twenty-one patients of autoimmune hemolytic anemia (AIHA), aged 2 months to 57 years were analyzed. The common presenting feature was pallor (89%), fever (38%), Jaundice (43%) and hepatomegaly and splenomegaly was seen in 76% and 81% respectively. Fifteen cases were of idiopathic etiology and in 6 cases the etiology could be identified as systemic lupus erythematosus, systemic sclerosis, pregnancy, maternal AIHA, typhoid fever and myelodysplastic syndrome (one each). Hemoglobin level ranged between 1.9 to 11.7 gm/dl (mean 6.8 gm/dl) and reticulocyte counts between 6% to 42% (mean (20.2%). Four patients had thrombocytopenia. Direct antiglobulin test (DAT) was positive in 19 and indirect antiglobulin test (IAT) in 7 cases. There was no correlation between DAT positivity and severity of anemia. All patients had warm antibodies of IgG type. Ten of fourteen patients responded to steroid therapy. Patients with secondary AIHA had a significantly poorer prognosis compared to the idiopathic group.

Adolescent↗

Cholestatic jaundice due to congenital Toxoplasma gondii infection.

A case of congenital toxoplasmosis manifesting as hepatosplenomegaly and cholestatic jaundice in a 4 month old child is reported. To the best of our knowledge this is the first report of cholestatic jaundice due to congenital toxoplasmosis from India. The child was successfully treated with sulphadiazine and pyremethamine combination.

Cholestasis, Intrahepatic↗